Cellular bases for human atrial fibrillation

Antony J. Workman, Kathleen A. Kane, Andrew C. Rankin

Research output: Contribution to journalArticle

52 Citations (Scopus)
9 Downloads (Pure)

Abstract

Atrial fibrillation (AF) causes substantial morbidity and mortality. It may be triggered and sustained by either reentrant or nonreentrant electrical activity. Human atrial cellular refractory period is shortened in chronic AF, likely aiding reentry. The ionic and molecular mechanisms are not fully understood and may include increased inward rectifier K+ current and altered Ca2+ handling. Heart failure, a major cause of AF, may involve arrhythmogenic atrial electrical remodeling, but the pattern is unclear in humans. Beta-blocker therapy prolongs atrial cell refractory period; a potentially antiarrhythmic influence, but the ionic and molecular mechanisms are unclear. The search for drugs to suppress AF without causing ventricular arrhythmias has been aided by basic studies of cellular mechanisms of AF. It remains to be seen whether such drugs will improve patient treatment.
Original languageEnglish
Pages (from-to)S1-S6
JournalHeart Rhythm
Volume5
Issue number6
Early online date17 Jan 2008
DOIs
Publication statusPublished - 30 Jun 2008

Fingerprint

Atrial Fibrillation
Atrial Remodeling
Pharmaceutical Preparations
Cardiac Arrhythmias
Heart Failure
Morbidity
Mortality
Therapeutics

Keywords

  • arrhythmias
  • atrial fibrillation
  • beta-blocker
  • electrical remodeling
  • heart failure
  • ion current
  • refractory period
  • transmembrane action potential
  • pharmacology

Cite this

Workman, A. J., Kane, K. A., & Rankin, A. C. (2008). Cellular bases for human atrial fibrillation. Heart Rhythm, 5(6), S1-S6. https://doi.org/10.1016/j.hrthm.2008.01.016
Workman, Antony J. ; Kane, Kathleen A. ; Rankin, Andrew C. / Cellular bases for human atrial fibrillation. In: Heart Rhythm. 2008 ; Vol. 5, No. 6. pp. S1-S6.
@article{64c2989fcbad4f7a8f6088916a9600a4,
title = "Cellular bases for human atrial fibrillation",
abstract = "Atrial fibrillation (AF) causes substantial morbidity and mortality. It may be triggered and sustained by either reentrant or nonreentrant electrical activity. Human atrial cellular refractory period is shortened in chronic AF, likely aiding reentry. The ionic and molecular mechanisms are not fully understood and may include increased inward rectifier K+ current and altered Ca2+ handling. Heart failure, a major cause of AF, may involve arrhythmogenic atrial electrical remodeling, but the pattern is unclear in humans. Beta-blocker therapy prolongs atrial cell refractory period; a potentially antiarrhythmic influence, but the ionic and molecular mechanisms are unclear. The search for drugs to suppress AF without causing ventricular arrhythmias has been aided by basic studies of cellular mechanisms of AF. It remains to be seen whether such drugs will improve patient treatment.",
keywords = "arrhythmias, atrial fibrillation, beta-blocker, electrical remodeling, heart failure, ion current, refractory period, transmembrane action potential, pharmacology",
author = "Workman, {Antony J.} and Kane, {Kathleen A.} and Rankin, {Andrew C.}",
year = "2008",
month = "6",
day = "30",
doi = "10.1016/j.hrthm.2008.01.016",
language = "English",
volume = "5",
pages = "S1--S6",
journal = "Heart Rhythm",
issn = "1547-5271",
number = "6",

}

Workman, AJ, Kane, KA & Rankin, AC 2008, 'Cellular bases for human atrial fibrillation', Heart Rhythm, vol. 5, no. 6, pp. S1-S6. https://doi.org/10.1016/j.hrthm.2008.01.016

Cellular bases for human atrial fibrillation. / Workman, Antony J.; Kane, Kathleen A.; Rankin, Andrew C.

In: Heart Rhythm, Vol. 5, No. 6, 30.06.2008, p. S1-S6.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cellular bases for human atrial fibrillation

AU - Workman, Antony J.

AU - Kane, Kathleen A.

AU - Rankin, Andrew C.

PY - 2008/6/30

Y1 - 2008/6/30

N2 - Atrial fibrillation (AF) causes substantial morbidity and mortality. It may be triggered and sustained by either reentrant or nonreentrant electrical activity. Human atrial cellular refractory period is shortened in chronic AF, likely aiding reentry. The ionic and molecular mechanisms are not fully understood and may include increased inward rectifier K+ current and altered Ca2+ handling. Heart failure, a major cause of AF, may involve arrhythmogenic atrial electrical remodeling, but the pattern is unclear in humans. Beta-blocker therapy prolongs atrial cell refractory period; a potentially antiarrhythmic influence, but the ionic and molecular mechanisms are unclear. The search for drugs to suppress AF without causing ventricular arrhythmias has been aided by basic studies of cellular mechanisms of AF. It remains to be seen whether such drugs will improve patient treatment.

AB - Atrial fibrillation (AF) causes substantial morbidity and mortality. It may be triggered and sustained by either reentrant or nonreentrant electrical activity. Human atrial cellular refractory period is shortened in chronic AF, likely aiding reentry. The ionic and molecular mechanisms are not fully understood and may include increased inward rectifier K+ current and altered Ca2+ handling. Heart failure, a major cause of AF, may involve arrhythmogenic atrial electrical remodeling, but the pattern is unclear in humans. Beta-blocker therapy prolongs atrial cell refractory period; a potentially antiarrhythmic influence, but the ionic and molecular mechanisms are unclear. The search for drugs to suppress AF without causing ventricular arrhythmias has been aided by basic studies of cellular mechanisms of AF. It remains to be seen whether such drugs will improve patient treatment.

KW - arrhythmias

KW - atrial fibrillation

KW - beta-blocker

KW - electrical remodeling

KW - heart failure

KW - ion current

KW - refractory period

KW - transmembrane action potential

KW - pharmacology

U2 - 10.1016/j.hrthm.2008.01.016

DO - 10.1016/j.hrthm.2008.01.016

M3 - Article

VL - 5

SP - S1-S6

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 6

ER -